• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析第一年体重过度增加与炎症、糖尿病及残余肾功能快速下降有关。

Excessive Weight Gain during the First Year of Peritoneal Dialysis Is Associated with Inflammation, Diabetes Mellitus, and a Rapid Decrease in Residual Renal Function.

作者信息

Kim Jwa-Kyung, Kim Young-Su, Song Young Rim, Kim Hyung Jik, Kim Sung Gyun, Moon Sung Jin

机构信息

Department of Internal Medicine, Kidney Research Institute, Hallym University Sacred Heart Hospital, Hallym University, Anyang, Korea.

Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.

出版信息

PLoS One. 2015 Sep 25;10(9):e0139033. doi: 10.1371/journal.pone.0139033. eCollection 2015.

DOI:10.1371/journal.pone.0139033
PMID:26406589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4583287/
Abstract

OBJECTIVES

Significant weight gain is a potential problem in most patients starting peritoneal dialysis (PD); however, few studies have explored the clinical effects of increased body weight (BW) in these patients. We evaluated the effect of excess weight gain during the first year after PD on residual renal function (RRF).

METHODS

A total of 148 incident PD patients were analyzed in a longitudinal observational study. The mean duration of follow-up was 23.8 months. RRF was measured at baseline (within 1 month of starting PD) and thereafter at 6-month intervals for 2-3 years or until loss of RRF. BW was measured at the time of RRF measurement, and excess weight gain was defined as a BW increase over the median value (3.0%).

RESULTS

The median 1-year increase in BW was 2.3kg (IQR, 1.01-4.58) or 3.0% (IQR, 1.13-5.31). The mean slope of RRF decline was -0.068 ± 0.053 mL/min/month/1.73m2, and RRF loss developed in 48 patients at a mean follow-up time of 19.4 ± 6.8 months. Patients with BW increases > 3.0% showed significantly increased RRF decline rate compared to those without excess weight gain (p<0.001), and the BW increase (%/year) correlated significantly with higher hs-CRP levels and RRF decline rate. High systolic blood pressure, diabetes, large amount of proteinuria and excess BW gain significantly influenced the RRF decline rate. Also, it increased the risk of RRF loss by 4.17-fold (95% confidence intervals, 1.87-9.28; p<0.001).

CONCLUSIONS

Excess weight gain during the first year of PD was closely linked to systemic inflammation, diabetes and rapid decline in RRF.

摘要

目的

显著体重增加是大多数开始腹膜透析(PD)患者的一个潜在问题;然而,很少有研究探讨这些患者体重(BW)增加的临床影响。我们评估了PD后第一年体重过度增加对残余肾功能(RRF)的影响。

方法

在一项纵向观察性研究中分析了总共148例新发PD患者。平均随访时间为23.8个月。在基线时(开始PD后1个月内)测量RRF,此后每6个月测量一次,持续2 - 3年或直至RRF丧失。在测量RRF时测量BW,体重过度增加定义为BW增加超过中位数(3.0%)。

结果

BW的中位数1年增加量为2.3kg(四分位间距,1.01 - 4.58)或3.0%(四分位间距,1.13 - 5.31)。RRF下降的平均斜率为-0.068±0.053 mL/min/月/1.73m²,48例患者出现RRF丧失,平均随访时间为19.4±6.8个月。与没有体重过度增加的患者相比,BW增加>3.0%的患者RRF下降率显著增加(p<0.001),且BW增加(%/年)与较高的hs-CRP水平和RRF下降率显著相关。高收缩压、糖尿病、大量蛋白尿和体重过度增加显著影响RRF下降率。此外,它使RRF丧失的风险增加4.17倍(95%置信区间,1.87 - 9.28;p<0.001)。

结论

PD第一年体重过度增加与全身炎症、糖尿病和RRF快速下降密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bd/4583287/e9fcd11ee5af/pone.0139033.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bd/4583287/e9fcd11ee5af/pone.0139033.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bd/4583287/e9fcd11ee5af/pone.0139033.g001.jpg

相似文献

1
Excessive Weight Gain during the First Year of Peritoneal Dialysis Is Associated with Inflammation, Diabetes Mellitus, and a Rapid Decrease in Residual Renal Function.腹膜透析第一年体重过度增加与炎症、糖尿病及残余肾功能快速下降有关。
PLoS One. 2015 Sep 25;10(9):e0139033. doi: 10.1371/journal.pone.0139033. eCollection 2015.
2
Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis.透析第一年期间炎症与残余肾功能及腹膜转运率变化之间的关联
Nephrol Dial Transplant. 2001 Nov;16(11):2240-5. doi: 10.1093/ndt/16.11.2240.
3
A Fast Decline of Residual Renal Function in the First Year is a Predictor for Early Withdrawal from Peritoneal Dialysis in Non-Diabetic Patients.第一年残余肾功能的快速下降是预测非糖尿病患者早期退出腹膜透析的指标。
Kidney Blood Press Res. 2019;44(1):12-21. doi: 10.1159/000497807. Epub 2019 Feb 22.
4
Predictors of decline of residual renal function in new peritoneal dialysis patients.新腹膜透析患者残余肾功能下降的预测因素
Perit Dial Int. 2003 May-Jun;23(3):276-83.
5
Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The ANZ Trial.腹膜透析患者残余肾功能下降的预测因素:澳新试验
Perit Dial Int. 2017 May-Jun;37(3):283-289. doi: 10.3747/pdi.2016.00206. Epub 2016 Dec 1.
6
Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.长期腹膜透析患者残余肾功能的下降速率与全因死亡率及技术失败相关。
Nephrol Dial Transplant. 2009 Sep;24(9):2909-14. doi: 10.1093/ndt/gfp056. Epub 2009 Feb 18.
7
Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.新腹膜透析患者残余肾功能、炎症与患者生存率之间的关联
Nephrol Dial Transplant. 2003 Mar;18(3):590-7. doi: 10.1093/ndt/18.3.590.
8
Effect of peritoneal dialysis modality on the 1-year rate of decline of residual renal function.腹膜透析方式对残余肾功能 1 年下降率的影响。
Yonsei Med J. 2014 Jan;55(1):141-8. doi: 10.3349/ymj.2014.55.1.141.
9
Baseline and Time-Averaged Values Predicting Residual Renal Function Decline Rate in Japanese Peritoneal Dialysis Patients.预测日本腹膜透析患者残余肾功能下降率的基线值和时间平均值
Ther Apher Dial. 2017 Dec;21(6):599-605. doi: 10.1111/1744-9987.12589. Epub 2017 Oct 19.
10
Definition and risk factors of rapidly declining residual renal function in peritoneal dialysis: an observational study.定义和快速下降的残余肾功能的腹膜透析的危险因素:一项观察性研究。
Kidney Blood Press Res. 2012;35(4):233-41. doi: 10.1159/000332887. Epub 2012 Jan 3.

引用本文的文献

1
Influencing factors for residual kidney function in incident peritoneal dialysis patients: a systematic review and meta-analysis.影响新进入腹膜透析患者残余肾功能的因素:系统评价和荟萃分析。
Ren Fail. 2023;45(2):2286328. doi: 10.1080/0886022X.2023.2286328. Epub 2023 Nov 30.
2
Obesity, Weight Gain, and Fluid Overload in Peritoneal Dialysis.腹膜透析中的肥胖、体重增加和液体超负荷
Front Nephrol. 2022 Jun 28;2:880097. doi: 10.3389/fneph.2022.880097. eCollection 2022.
3
Impact of Weight Gain on the Subsequent Survival of New Peritoneal Dialysis Patients.

本文引用的文献

1
Association between bioimpedance analysis parameters and left ventricular hypertrophy in peritoneal dialysis patients.腹膜透析患者生物电阻抗分析参数与左心室肥厚之间的关联
Int Urol Nephrol. 2014 Sep;46(9):1851-6. doi: 10.1007/s11255-014-0709-y. Epub 2014 Apr 9.
2
Obesity paradox in end-stage kidney disease patients.终末期肾病患者的肥胖悖论。
Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):415-25. doi: 10.1016/j.pcad.2013.10.005. Epub 2013 Oct 9.
3
Adverse effects of systemic glucose absorption with peritoneal dialysis: how good is the evidence?
体重增加对新腹膜透析患者后续生存的影响。
Kidney Dis (Basel). 2023 Jan 17;9(3):197-205. doi: 10.1159/000529186. eCollection 2023 May.
4
Elevated Ferritin Levels Associated with High Body Fat Mass Affect Mortality in Peritoneal Dialysis Patients.铁蛋白水平升高与体脂肪量高相关,影响腹膜透析患者的死亡率。
Nutrients. 2023 Apr 29;15(9):2149. doi: 10.3390/nu15092149.
5
Adipose and Plasma microRNAs miR-221 and 222 Associate with Obesity, Insulin Resistance, and New Onset Diabetes after Peritoneal Dialysis.脂肪组织和血浆 microRNAs miR-221 和 222 与腹膜透析后肥胖、胰岛素抵抗和新发糖尿病相关。
Nutrients. 2022 Nov 18;14(22):4889. doi: 10.3390/nu14224889.
6
On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease.在终末期肾病的临床结局中,残余肾功能相互作用的重要性。
J Nephrol. 2022 Dec;35(9):2191-2204. doi: 10.1007/s40620-022-01388-9. Epub 2022 Jul 11.
7
Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease.慢性肾脏病患者残余肾功能的认识与管理进展
Kidney Dis (Basel). 2017 Jan;2(4):187-196. doi: 10.1159/000449029. Epub 2016 Sep 7.
腹膜透析中全身葡萄糖吸收的不良影响:证据有多大把握?
Curr Opin Nephrol Hypertens. 2013 Nov;22(6):663-8. doi: 10.1097/MNH.0b013e328365b3d1.
4
Body-Mass Index and All-Cause Mortality in US Adults With and Without Diabetes.美国有糖尿病和无糖尿病成年人的体重指数与全因死亡率
J Gen Intern Med. 2014 Jan;29(1):25-33. doi: 10.1007/s11606-013-2553-7. Epub 2013 Aug 9.
5
Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study.巴西腹膜透析多中心研究中,起始腹膜透析患者的体表面积和纵向体重变化不会增加死亡率。
Clinics (Sao Paulo). 2013 Jan;68(1):51-8. doi: 10.6061/clinics/2013(01)oa08.
6
Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis.蛋白尿:慢性血液透析中炎症和心血管疾病的一个被忽视的标志物。
Int J Nephrol Renovasc Dis. 2012;5:1-7. doi: 10.2147/IJNRD.S27675. Epub 2011 Dec 23.
7
Longitudinal body composition changes due to dialysis.由于透析导致的纵向身体成分变化。
Clin J Am Soc Nephrol. 2011 Jul;6(7):1668-75. doi: 10.2215/CJN.06790810.
8
Inflammation, oxidative stress, and obesity.炎症、氧化应激与肥胖。
Int J Mol Sci. 2011;12(5):3117-32. doi: 10.3390/ijms12053117. Epub 2011 May 13.
9
Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.维持性血液透析患者肥胖与心血管危险因素之间的关系
J Ren Nutr. 2009 Sep;19(5):357-64. doi: 10.1053/j.jrn.2009.04.002. Epub 2009 Jul 10.
10
Systemic and local inflammation in peritoneal dialysis: mechanisms, biomarkers and effects on outcome.
Contrib Nephrol. 2009;163:132-139. doi: 10.1159/000223791. Epub 2009 Jun 3.